|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: J Torre LA: Global cancer statistics. CA Cancer J
Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hisamatsu T, Mabuchi S, Yoshino K, Fujita
M, Enomoto T, Hamasaki T and Kimura T: Prediction of
progression-free survival and response to paclitaxel plus
carboplatin in patients with recurrent or advanced cervical cancer.
Int J Gynecol Cancer. 22:623–629. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zamore PD and Haley B: Ribo-gnome: The big
world of small RNAs. Science. 309:1519–1524. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee RC, Feinbaum RL and Ambros V: The
C. elegans heterochronic gene lin-4 encodes small RNAs with
antisense complementarity to lin-14. Cell. 75:843–854. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
He X, He L and Hannon GJ: The guardian's
little helper: microRNAs in the p53 tumor suppressor network.
Cancer Res. 67:11099–11101. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hermeking H: p53 enters the microRNA
world. Cancer Cell. 12:414–418. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bommer GT, Gerin I, Feng Y, Kaczorowski
AJ, Kuick R, Love RE, Zhai Y, Giordano TJ, Qin ZS, Moore BB, et al:
p53-mediated activation of miRNA34 candidate tumor-suppressor
genes. Curr Biol. 17:1298–1307. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kinoshita T, Hanazawa T, Nohata N, Kikkawa
N, Enokida H, Yoshino H, Yamasaki T, Hidaka H, Nakagawa M, Okamoto
Y, et al: Tumor suppressive microRNA-218 inhibits cancer cell
migration and invasion through targeting laminin-332 in head and
neck squamous cell carcinoma. Oncotarget. 3:1386–1400. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martinez I, Gardiner AS, Board KF, Monzon
FA, Edwards RP and Khan SA: Human papillomavirus type 16 reduces
the expression of microRNA-218 in cervical carcinoma cells.
Oncogene. 27:2575–2582. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Võsa U, Vooder T, Kolde R, Vilo J,
Metspalu A and Annilo T: Meta-analysis of microRNA expression in
lung cancer. Int J Cancer. 132:2884–2893. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schetter AJ, Okayama H and Harris CC: The
role of microRNAs in colorectal cancer. Cancer J. 18:244–252. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gu J, Li X, Liang Y, Qiao L, Ran D, Lu Y,
Li X, Wei W and Zheng Q: Upregulation of URI/RMP gene expression in
cervical cancer by high-throughput tissue microarray analysis. Int
J Clin Exp Pathol. 6:669–677. 2013.PubMed/NCBI
|
|
14
|
Fassan M, Croce CM and Rugge M: miRNAs in
precancerous lesions of the gastrointestinal tract. World J
Gastroenterol. 17:5231–5239. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao JJ, Lin J, Lwin T, Yang H, Guo J,
Kong W, Dessureault S, Moscinski LC, Rezania D, Dalton WS, et al:
MicroRNA expression profile and identification of miR-29 as a
prognostic marker and pathogenetic factor by targeting CDK6 in
mantle cell lymphoma. Blood. 115:2630–2639. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yamakuchi M, Ferlito M and Lowenstein CJ:
miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci
USA. 105:13421–13426. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tarasov V, Jung P, Verdoodt B, Lodygin D,
Epanchintsev A, Menssen A, Meister G and Hermeking H: Differential
regulation of microRNAs by p53 revealed by massively parallel
sequencing: miR-34a is a p53 target that induces apoptosis and
G1-arrest. Cell Cycle. 6:1586–1593. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yan D, Zhou X, Chen X, Hu DN, Dong XD,
Wang J, Lu F, Tu L and Qu J: MicroRNA-34a inhibits uveal melanoma
cell proliferation and migration through downregulation of c-Met.
Invest Ophthalmol Vis Sci. 50:1559–1565. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao C, Zhang Z, Liu W, Xiao S, Gu W and Lu
H: Reduced microRNA-218 expression is associated with high nuclear
factor kappa B activation in gastric cancer. Cancer. 116:41–49.
2010.PubMed/NCBI
|
|
20
|
Iorio MV, Casalini P, Tagliabue E, Ménard
S and Croce CM: MicroRNA profiling as a tool to understand
prognosis, therapy response and resistance in breast cancer. Eur J
Cancer. 44:2753–2759. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Weng OL, Pourmand N and Patterson BK:
Patterns of known and novel small RNAS in human cervical cancer.
Cancer Res. 67:6031–6043. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Raver-Shapira N, Marciano E, Meiri E,
Spector Y, Rosenfeld N, Moskovits N, Bentwich Z and Oren M:
Transcriptional activation of miR-34a contributes to p53-mediated
apoptosis. Mol Cell. 26:731–743. 2007. View Article : Google Scholar : PubMed/NCBI
|
